arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Alector, Inc.

ALEC
$2.07 ▼ -0.22 (-9.61%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
10 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
49
Health
Weak
Neutral
auto_awesome

Analytical Summary

Alector, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $213.2M
Dividend Yield —
Revenue Growth -79.1% ↘
Op. Margin None
ROIC -384.2% ↘
FCF / Share $-1.79 ↗
Trailing P/E —
Price / Book 7.5x
FCF Yield —
Debt / Equity 0.34
info Valuation on last close. End-of-day price, Nov 5, 2026.

10-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$21.05M
↓ -79.1% —
Net Income Profit after all expenses
$-142.93M
↓ -20.1% —
Operating Margin Operating profit as % of sales
-144.2%
↑ +7.7% —
FCF / Share Free cash flow per share
$-1.79
↑ +25.3% —
Long-Term Debt Long-term obligations
$10.00M
↑ +6.5% —

Health Breakdown

Financial Health
35
Cash Quality
75

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 10 years · 36 quarters